Oral 24-week probiotics supplementation did not decrease cardiovascular risk markers in patients with biopsy proven NASH: A double-blind placebo-controlled randomized study Samantha Thifani Alrutz Barcelos; Amanda Souza Silva-Sperb; Helena Abadie Moraes; Larisse Longo; Bruna Concheski de Moura; Matheus Truccolo Michalczuk; Carolina Uribe-Cruz; Carlos Thadeu Schmidt Cerski; Themis Reverbel da Silveira; Valesca Dall'Alba; Mário Reis Álvares-da-Silva;

Clinically significant portal hypertension in patients with primary biliary cholangitis: Clinicopathological features and prognostic value Ying Zhang; Huaying Lai; Jing Chen; Ruimin Lai; Xiaoyu Lin; Shan Lin; Bingping Liu; Qiuxiang Lin; Bin Wang; Qi Zheng;

The Toulouse algorithm identifies patients with increased risk of cardiac decompensation only in patients with TIPS for refractory ascites Emma Vanderschueren; Youri Bekhuis; Jan Clerick; Jappe Decock; Philippe Meersseman; Alexander Wilmer; Eveline Claus; Lawrence Bonne; Guido Claessen; Chris Verslype; Geert Maleux; Wim Laleman;